SLC-500

N/A

Report date: 2024/05/23 16:24:19
NME

Base Information

Drug NameSLC-500
Drug Alias NameSLC-500
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMacrophage-stimulating protein receptor inhibitors
TargetsMacrophage-stimulating protein receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSignalchem Lifesciences Co
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A